Drug Profile
BM 920700
Latest Information Update: 15 Mar 2007
Price :
$50
*
At a glance
- Originator Roche
- Class Antineoplastics; Nucleotides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer